articleTop 1% cited
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Archives of Dermatology · 2000 · Vol. 136(3) · pp. 323–7
I. García‐Doval✉(Complejo Hospitalario de Pontevedra)Laurence Le CleachHélène BocquetXose-Luis OteroJean‐Claude Roujeau
Abstract
Prompt withdrawal of drug(s) that are suspected to cause SJS or TEN may decrease mortality. Prompt withdrawal of causative drugs should be a priority when blisters or erosions appear in the course of a drug eruption.
Drug-Induced Adverse ReactionsUrticaria and Related ConditionsAutoimmune Bullous Skin DiseasesToxic epidermal necrolysisMedicineOdds ratioConfidence intervalDrug withdrawalConfoundingIntensive care unitPediatricsInternal medicineDermatology
MeSH terms
AdultAgedAnimalsPharmaceutical PreparationsFemaleHalf-LifeHumansLongitudinal StudiesMaleMiddle AgedPrognosisStevens-Johnson SyndromeTime FactorsLogistic ModelsOdds Ratio
Citations
485
FWCI
13.95
field-weighted impact
References
24
Percentile
99%
vs. same field & year
Citations per year
Cited by
International<scp>Con</scp>sensus on drug allergy
Allergy · 2014 · 906 citations
ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
Clinical Pharmacology & Therapeutics · 2010 · 715 citations
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
Journal of Investigative Dermatology · 2000 · 1,163 citations
References
Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme
Archives of Dermatology · 1993 · 1,607 citations
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Archives of Dermatology · 1991 · 402 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
